Tag: KDC-MN-1344

  • SLU-PP-332

    Pan-ERR (estrogen-related receptor) agonist exercise mimetic

    A small-molecule pan-agonist of the three estrogen-related receptor isoforms (ERRฮฑ, ERRฮฒ, ERRฮณ), studied as an exercise mimetic for activation of mitochondrial biogenesis and oxidative metabolism.

    Abstract

    SLU-PP-332 (CAS 2226909-79-9; molecular formula C25H26N2O5S; molecular weight 466.55) is a small-molecule pan-agonist of the estrogen-related receptor (ERR) family of orphan nuclear receptors developed at the Saint Louis University School of Medicine by Thomas Burris and colleagues. The ERR family comprises three isoforms (ERRalpha, ERRbeta, ERRgamma) that share substantial sequence homology with the estrogen receptor but bind distinct ligands and target distinct gene programs; the principal ERR-regulated gene programs include mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and skeletal muscle oxidative fiber phenotype. ERR activity is induced by exercise and is one of the principal transcriptional drivers of the exercise-induced metabolic adaptation phenotype, alongside PGC-1alpha (which is itself an ERR coactivator). SLU-PP-332 was characterized as an inverse partial agonist or full agonist depending on the assay, with similar potency at all three ERR isoforms (EC50 in the low-nanomolar to mid-nanomolar range). The pharmacological profile has motivated interest in the compound as an exercise mimetic for metabolic and aging indications. The compound is research-grade and not approved by any regulatory authority; clinical development through partner companies has been announced but no Phase 1 readouts have been published as of the most recent monograph revision.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.